Migraine Medication Copay Cards 2026: Ubrelvy, Nurtec, Qulipta & CGRP Savings
Updated July 2026 · 7 min read
CGRP migraine medications changed what's possible for chronic and episodic migraine patients - but the sticker prices are intimidating. Ubrelvy runs about $1,000+ for 10 tablets, Nurtec ODT around $1,000/month, Qulipta about $1,050/month, and the injectable CGRPs (Emgality, Aimovig, Ajovy) hover near $700/month. Vyepti IV infusions are billed in the thousands per dose.
Almost no one in NYC pays those numbers. Every one of these medications has a manufacturer copay program that lands eligible commercial patients at $0/month. Here's how each one works, side by side.
Migraine Copay Card Comparison (2026)
| Medication | Type | Copay Program | Eligible Copay |
|---|---|---|---|
| Ubrelvy (ubrogepant) | Oral acute (gepant) | Ubrelvy Savings Card (AbbVie) | As low as $0/fill |
| Nurtec ODT (rimegepant) | Oral acute + prevention | Nurtec ODT Savings Program (Pfizer) | As low as $0/fill |
| Qulipta (atogepant) | Oral prevention (gepant) | Qulipta Complete (AbbVie) | As low as $0/mo |
| Emgality (galcanezumab) | Injectable prevention (CGRP mAb) | Emgality Savings Card (Lilly) | $0/mo, first 12 months free for eligible new patients |
| Aimovig (erenumab) | Injectable prevention (CGRP mAb) | Aimovig Ally / Aimovig Copay Card | As low as $5/mo |
| Ajovy (fremanezumab) | Injectable prevention (CGRP mAb) | Ajovy Copay Savings Program | As low as $5/mo |
| Vyepti (eptinezumab) | IV infusion prevention | Vyepti Copay Assistance | As low as $0/infusion |
| Zavzpret (zavegepant) | Nasal spray acute | Zavzpret Savings Program (Pfizer) | As low as $0/fill |
All copay programs exclude Medicare, Medicaid, TRICARE, VA, and other government insurance. Annual benefit caps apply. Pricing subject to change.
Acute Treatment: Ubrelvy, Nurtec ODT & Zavzpret
The oral and nasal gepants replaced triptans for a lot of NYC patients - fewer cardiovascular contraindications, no vasoconstriction, and they still work when triptans have already failed. The copay card story for all three is roughly the same:
- Ubrelvy Savings Card: $0/fill for eligible commercial patients, annual benefit cap set by AbbVie.
- Nurtec ODT Savings Program: $0/fill for both acute and preventive dosing. One of the few gepants approved for prevention as well as acute treatment.
- Zavzpret Savings Program: $0/fill nasal spray, useful when nausea makes oral treatment impractical.
The trap here is prior authorization. Most commercial plans require step therapy through triptans (or a documented contraindication) before covering a gepant. If your PA gets denied, we help your prescriber submit an appeal instead of you paying full cash.
Oral Prevention: Qulipta
Qulipta (atogepant) is the first oral CGRP prevention medication - a daily tablet instead of a monthly injection. The Qulipta Complete Savings Card covers the first three fills at $0 for eligible commercial patients, then continues at a low copay through the annual benefit cap.
Injectable Prevention: Emgality, Aimovig & Ajovy
These are self-administered monthly (or quarterly) injections targeting the CGRP pathway. Copay programs:
- Emgality (Lilly): eligible new commercial patients get the first 12 months free through the Emgality Savings Card, then $0/month up to the annual cap.
- Aimovig (Amgen/Novartis): Aimovig Ally program includes free trial doses for new patients, then $5/month copay for eligible commercial patients.
- Ajovy (Teva): Ajovy Copay Savings Program covers eligible commercial patients down to $5/month.
Which one wins for you comes down to: your plan's preferred CGRP (formulary tier), whether you prefer monthly vs quarterly dosing (Ajovy has a quarterly option), and injector preference. We run all three at intake so you're not guessing.
IV Prevention: Vyepti
Vyepti (eptinezumab) is an IV infusion every three months, administered in-office or at an infusion center. Buy-and-bill programs and Vyepti Copay Assistance typically bring eligible commercial patients to $0 per infusion. We coordinate with your neurologist's office when they order product through us.
Botox for Chronic Migraine
Botox (onabotulinumtoxinA) is FDA-approved for chronic migraine (15+ headache days per month). The Botox Savings Program covers eligible commercial patients down to $0 out-of-pocket, and we work directly with neurology practices on buy-and-bill.
If You Have Medicare or Medicaid
Manufacturer copay cards exclude government insurance, but every one of these manufacturers runs a patient assistance program for lower-income patients:
- myAbbVie Assist - Ubrelvy, Qulipta (free medication for qualifying patients)
- Pfizer RxPathways - Nurtec ODT, Zavzpret
- Lilly Cares Foundation - Emgality
- Amgen SupportPlus - Aimovig
- Teva Shared Solutions - Ajovy
- Independent foundations - HealthWell, PAN Foundation (grant-based, when open)
Why an Independent Specialty Pharmacy Matters for Migraine Meds
- Cold-chain injectables done right. Emgality, Aimovig, Ajovy, and Vyepti all need to stay 36-46°F. We deliver same-day in medical cooling packaging - no cardboard box on a summer stoop.
- Prior auth coordination. Migraine prior auths are notoriously step-therapy heavy. We document appeals and coordinate peer-to-peer requests with your prescriber's office instead of just telling you it was denied.
- Copay card re-enrollment. Every card resets January 1. We re-enroll you automatically so you don't lose the $0 copay.
- One pharmacist per patient. Not whoever is at the counter.
Get Your Migraine Medication Priced Today
Call us or transfer your Ubrelvy, Nurtec, Qulipta, Emgality, Aimovig, Ajovy, or Vyepti prescription to 79th Street Pharmacy. We'll come back the same day with the exact copay after every savings program is applied.
79th Street Pharmacy
215 W 79th Street, New York, NY 10024
(646) 370-5978 · Mon-Fri 9am-6pm · Sat 10am-3pm
See our specialty medications page for the complete list of neurology and specialty biologics we stock.